Please assess the completion status of the following clinical trial:

Trial Title: Early Cancer Detection Test - Lung Cancer Scotland

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Participant is willing and able to give informed consent for participation in the study~2. Male or female aged 50 years to 75 years~3. Current or Ex-smoker with at least 20 year pack history~4. or Less than 20 year pack history but with family history of lung cancer in a 1st degree relative (mother, father, sister, brother, child)~5. ECOG Status: 0, 1 and 2 (Eastern Co-operative Oncology Group) Grade ECOG 0 Fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours~6. Geographical postal sectors of:~NHS Geographical Area Eligible Postcodes Tayside DD1 - DD11, PH1-PH3 , PH6-PH8, PH10, PH11, PH13, PH15 \& PH16 Greater Glasgow \& Clyde G1-G5, G11 -G15, G20-G22, G31-34, G40 -G46, G51- G53, G60-G62 \&G64, G66 \& G69, G72 \& G73, G76-G78, G81-G83 PA1-PA8 (except PA6), PA11-PA16 \& PA19~Exclusion Criteria:~1. History of any cancer other than non-melanomatous skin cancer, cervical cancer in situ.~2. Symptoms suggestive of lung cancer within past 6 months (haemoptysis, unintentional weight loss (at least 5% in preceding 6 months).~3. Patients for whom the GP considers invitation to the study would cause undue distress.~4. Patients with other terminal disease.~5. Patients on prolonged / continuous use (\> 3months) of cytotoxic/ immuno-suppressant drugs eg: Cyclophosphamide. Monotherapy using glucocorticoids/ steroids eg prednisolone is NOT an exclusion criteria.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Control (Type: NO_INTERVENTION): participants monitored for 10 years for lung cancer incidence.
- Early CDT Lung Test (Type: ACTIVE_COMPARATOR): Early CDT lung blood test

Based on this trial design, predict the completion outcome and termination type (if applicable).